| NUM | TITLE | DATE | VIEW |
|---|---|---|---|
| 4 | Project MB201 selected as National New Drug Development Project (2022.05.10) | 2022-05-11 | 930 |
| 3 | Patent registered at Korea Intellectual Property Office regarding bispecific antibody platform technology | 2022-04-01 | 1099 |
| 2 | Project MB101 selected as National New Drug Development Project (2021.11.12) | 2021-12-24 | 702 |
| 1 | Mustbio raises KRW 9 billion in Series A to develop multispecific antibodies | 2021-07-20 | 573 |
